Search

everythinglearnresearchcommunity

for

Search:↓

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

COVID-19 may cause temporary hair loss in some people.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A protein called MPZL3 in mitochondria slows down hair growth and could be a target for treating hair growth disorders.

Hair keratin treatments can be harmful, potentially causing health issues like skin reactions and cancer.

Myoepithelial cells can repair airways after severe injury.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.